Clinical trial
Hematopoietic Stem Cell Transplantation for Treatment of Multiple Sclerosis in Sweden - a Register-based Retrospective Observational Study
NCT05029206 is registered in ClinicalTrials.gov with Uppsala University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Hematopoietic Stem Cell Transplantation for Treatment of Multiple Sclerosis in Sweden - a Register-based Retrospective Observational Study
- Lead sponsor
- Uppsala University
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 5, 2021
- Completion date
- September 30, 2022
- Enrollment
- 174 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.